References
- RingsdrorfHStructure and properties of pharmacologically active polymersJ Polym Sci Polymer Symp197551135153
- CaiolfaVRZamaiMFioriniAPolymer-bound camptothecin: initial biodistribution and antitumor activity studiesJ Control Release20006510511910699275
- MalikNEvagorouEGDuncanRDendrimer-Platinate: a novel approach to cancer chemotherapyAnti-cancer Drugs199910876777610573209
- RoyRRecent developments in the rational design of multivalent glycoconjugatesTop Curr Chem1997187241274
- DuncanRIzzoLDendrimer biocompatibility and toxicityAdv Drug Del Rev20055722152237
- HowellBAFanDRakeshLAbd-EL-AzizASCarraherCEJPittmanCUJZeldinMNanoscale dendrimer-platinum conjugates as multivalent antitumor drugsInorganic and organometallic macromolecules: design and applications1st edNew YorkSpringer2007269294
- ZutphenSVReedijkJTargeting platinum antitumor drugs: overview of strategies employed to reduce systemic toxicityCoord Chem Rev20052492428452853
- RosenbergBVancampLTroskoJFMansourVHPlatinum compound: a new class of potent antitumor agentsNature19672223853965782119
- KartalouMEssiqmannJMMechanisms of resistance to cisplatinMutat Res200147812234311406166
- StewartDJMechanism of resistance to cisplatin and carboplatinCrit Rev Oncol Hematol2007631123117336087
- HoracekPDrobnikJInteraction of cis-diamminedichloroplatinum (II) with DNABiochim Biophys Acta19712543413475002798
- MicetichKCBarnesDEricksonLCA comparative study of the cytotoxicity and DNA damaging effects of cis-(diammino)(1,1-cyclo-butanedicarboxylato-platinum (II) on L1210 cellsCancer Res198545404340473896476
- HaniganMHDevarajanPCispaltin nephrotoxicity: molecular mechanismsCancer Ther20031476118185852
- GrothSNielsonHSorensonJBAcute and long term nephrotoxicity of cisplatin in manCancer Chemother Pharmacol1986171911962424627
- NamaziHAdeliMNovel linear-globular thermoreversible hydrogel ABA type copolymers from dendritic citric acid as the A blocks and poly (ethyleneglycol) as the B blockEur Polym J20033914911500
- NamaziHAdeliMDendrimers of citric acid and poly (ethylene glycol) as the new drug-delivery agentsBiomaterials2005261175118315451637
- BlagosklonnyMVProspective strategies to enforce selectively cell death in cancer cellsOncogene2004232967297515077157
- MosmannTRapid colorimetric assay for cellular growth and survival: application for proliferation and cytotoxicity assayJ Immuno Methods1983655563
- AdeliMMirabNShafiee AlavidjehMSobhaniZAtyabiFCarbon nanotubes-graft-polyglycerol: Biocompatible hybrid material in nano-medicinePolymer20095035283536
- IwasakiYIjuinMMikamiANakabayashiNIshiharaKBehavoir of blood cells in contact with water-soluble phospholipid polymerJ Biomed Mater Res19994636036710397993
- VermesIHaanenCSteffenSNakkenHReuteligspergerCA novel assay for apoptosis: flow cytometry detection of phosphatidyl serine expression on early apoptotic cells using fluorecein-labeld AnnexinJ Immuno Methods19951843951
- GianasiEBuckleyRGLatigoJWasilMDuncanRHPMA copolymers platinates containing dicarboxylato ligands, preparation, characterisation and in vitro and in vivo evaluationJ Drug Target200210754955612683722
- AmaravadiRKThompsonCBThe roles of therapy-induced autophagy and necrosis in cancer treatmentClin Cancer Res200713247271727918094407
- FerrutiPRanucciETrottaFGianasiESynthesis, characterisation and antitumor activity of platinum(II) complexes of novel functionalized poly (amidoamine)sMacromol Chem Phys199920016441654
- RenYZhangHHuangJSynthesis and cytotoxic activity of platinum complex immobilized by branched polyethylene glycolBioorg and Med Chem Lett200514479448316085413
- MistryPKellandLRLohSYComparison of celluar accumulation and cytotoxicity of cisplatin with that of tetra platinum and amminied-ibutyratodichloro (cyclohexylamine)platinum (IV) (JM221) in human ovarian carcinoma cell linesCancer Res199252618861971423261
- BergJMTymoczkoJLStryerLBiochemistry5th edNew YorkWH Freeman and Company2002465484
- NgCPBonavidaBA new challenge for successful immunotherapy by tumors that are resistant to apoptosis: two complementary signals to overcome cross resistanceAdv Cancer Res20028514517412374285
- GalluciSLolkemaMMatzingerPNatural adjuvants: endogenous activators of dendritic cellsNat Med199951249125510545990
- SauterBAlbertMLFranciscoLConsequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cellsJ Exp Med200019142343010662788